Accretion Pharmaceuticals Ltd IPO Price Range is ₹96 - 101, with a minimum investment of ₹1,21,200 for 1200 shares.
₹1,21,200
/ 1200 shares
Minimum Investment
View Accretion Pharmaceuticals Ltd IPO details including price range, minimum investment, lot size, financials, and IPO timeline. Get subscription updates, peer comparison, and key insights to help you make an informed decision.
IPO Status
Price Band
₹96 - 101
Open Date
2025-05-14
Close Date
2025-05-16
IPO Size
₹29.75 Cr
Lot Size
1200 shares
Min Investment
₹1,21,200
Listing Exchange
NSE
IPO subscribed over
🚀 7.315x
This IPO has been subscribed by 10.546x in the retail category and 4.874x in the QIB category.
Total Subscription | 7.315x |
Retail Individual Investors | 10.546x |
Qualified Institutional Buyers | 4.874x |
Non Institutional Investors | 4.409x |
Name | Accretion Pharmaceuticals Ltdx |
Experienced Promoters and Management Team.
Consistently supplying quality products to our valued customers in time.
Continually improving the quality standards by implementing process control and prevention techniques.
Long-standing relationship with clients and suppliers.
Quality standards.
Legacy Business Process & Management.
Strong and experienced R&D team.
A significant portion of its revenue is derived from exports, and any decline in exportprofitability may adversely impact its overall financial performance.
The Company operates in pharmaceutical sector, which is extensively regulated, any failures onthe company part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financialcondition.
Its manufacturing units are subject to periodic inspections and audits by regulatory authoritiesand clients. Its may be subject to regulatory action which may damage the company reputation leading to an adverse effect on its business, results of operations, financial condition and cash flows.
The company has a very limited operating history as a Company, which may make it difficult for investors to evaluate its historical performance or future prospects.
The company has only one Manufacturing Facility, continued operations of its manufacturing facility is critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on the company business, results of operations and financial condition.
The company generate a significant percentage of its revenue from few clients. The loss of any one or more of the company major clients would have a material adverse effect on its business operations and profitability.
Its inability to accurately forecast demand for the company products or manage its inventory or working capital requirements may have an adverse effect on the company business, results of operations and financial condition.
There was a Criminal litigation against its promoters cum directors and the company is not sure the same shall not be refiled by the concerned authority. In the event it is refiled, the interest of the promoters may divert from the business of the Company, which may adversely affect the business of the Company.
Its business operations are working capital intensive, and any inability to meet the company working capital requirements may adversely impact its financial condition and growth prospects.
The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.
1
Download the INDmoney app and complete your KYC to open an account.
2
Go to the INDstocks section and tap on IPO, or search for ‘IPO’.
3
Select Accretion Pharmaceuticals Ltd IPO from the list of live IPOs.
4
View key details like price band, lot size, and dates, then tap ‘Apply Now’.
5
Choose the number of lots and place your order via UPI.
6
Your funds will be blocked until the share allotment is finalized.